Correlation Between Sanofi ADR and Gilead Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sanofi ADR and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sanofi ADR and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sanofi ADR and Gilead Sciences, you can compare the effects of market volatilities on Sanofi ADR and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sanofi ADR with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sanofi ADR and Gilead Sciences.

Diversification Opportunities for Sanofi ADR and Gilead Sciences

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Sanofi and Gilead is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi ADR and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Sanofi ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sanofi ADR are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Sanofi ADR i.e., Sanofi ADR and Gilead Sciences go up and down completely randomly.

Pair Corralation between Sanofi ADR and Gilead Sciences

Considering the 90-day investment horizon Sanofi ADR is expected to generate 1.44 times less return on investment than Gilead Sciences. But when comparing it to its historical volatility, Sanofi ADR is 1.01 times less risky than Gilead Sciences. It trades about 0.14 of its potential returns per unit of risk. Gilead Sciences is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  8,772  in Gilead Sciences on November 18, 2024 and sell it today you would earn a total of  1,636  from holding Gilead Sciences or generate 18.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Sanofi ADR  vs.  Gilead Sciences

 Performance 
       Timeline  
Sanofi ADR 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi ADR are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Sanofi ADR showed solid returns over the last few months and may actually be approaching a breakup point.
Gilead Sciences 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating essential indicators, Gilead Sciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Sanofi ADR and Gilead Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sanofi ADR and Gilead Sciences

The main advantage of trading using opposite Sanofi ADR and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sanofi ADR position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.
The idea behind Sanofi ADR and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas